Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 45/100

Failure Rate

0.0%

0 terminated/withdrawn out of 3 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

0%

0 of 1 completed trials have results

Key Signals

1 recruiting

Enrollment Performance

Analytics

N/A
2(100.0%)
2Total
N/A(2)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (3)

Showing 3 of 3 trials
NCT07672977Not ApplicableEnrolling By Invitation

Home-Based Closed-Loop Auditory Stimulation to Enhance Slow-Wave Activity in MCI Due to Alzheimer's Disease: A Proof-of-Concept Study

Role: lead

NCT07402590Not ApplicableCompleted

Auditory Stimulation During Sleep to Enhance Long-Term Memory in Amnestic MCI

Role: lead

NCT06993207Recruiting

HOme-based Brain Monitoring With a GARment-EEG to Study Cognitive Decline in the Aging Population

Role: lead

All 3 trials loaded